Details for New Drug Application (NDA): 208837
✉ Email this page to a colleague
The generic ingredient in LEVOTHYROXINE SODIUM is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
Summary for 208837
Tradename: | LEVOTHYROXINE SODIUM |
Applicant: | Dr Reddys |
Ingredient: | levothyroxine sodium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | 100MCG/VIAL | ||||
Approval Date: | Mar 27, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription